News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Regeneron Pharmaceuticals, Inc. (REGN), Bayer HealthCare (BAY) Say Eye Drug Meets Mid-stage Goal



2/18/2010 7:55:47 AM

Bookmark and Share

Reuters -- Regeneron Pharmaceuticals and Bayer HealthCare, a U.S. unit of Germany's Bayer, said their experimental drug to treat retinal swelling brought on by diabetes, met its primary goal in a mid-stage study.

Read at Reuters
Read at AP


comments powered by Disqus
Reuters
AP
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES